Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Giulio Marchesini(University of Bologna), Mario Rizzetto(University of Turin)
Cited by 2,679
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
|Diabetologia|2005|759
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
|Journal of Viral Hepatitis|2011|234
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2019|152